These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 3428723)

  • 1. Morphometric and ultrastructural study of experimental venous thrombosis. Effects of defibrotide, an antithrombotic agent.
    Fumagalli G; Angelaccio E; Lombardo N; Clementi F
    Haemostasis; 1987; 17(6):361-70. PubMed ID: 3428723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombolytic activity of defibrotide: a morphometric evaluation in experimental venous thrombosis.
    Fumagalli G; Sala C; Angelaccio E; Lombardo N; Clementi F
    Pharmacol Res; 1989; 21(3):293-8. PubMed ID: 2748512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defibrotide is antithrombotic and thrombolytic against rabbit venous thrombosis.
    Niada R; Pescador R; Porta R; Mantovani M; Prino G
    Haemostasis; 1986; 16 Suppl 1():3-8. PubMed ID: 3519381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defibrotide therapy for thrombophlebitis--controlled clinical trial.
    Di Perri T; Vittoria A; Messa GL; Cappelli R
    Haemostasis; 1986; 16 Suppl 1():42-7. PubMed ID: 3754835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolution of superficial vein thrombosis treated with defibrotide: comparison with low dose subcutaneous heparin.
    Belcaro G
    Int J Tissue React; 1990; 12(5):319-24. PubMed ID: 2098372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute effects of defibrotide, an experimental antithrombotic agent, on fibrinolysis and blood prostanoids in man.
    Coccheri S; Biagi G; Legnani C; Bianchini B; Grauso F
    Eur J Clin Pharmacol; 1988; 35(2):151-6. PubMed ID: 3191933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of defibrotide on thromboembolism in the pulmonary vasculature of mice and rabbits and in the cerebral vasculature of rabbits.
    Paul W; Gresele P; Momi S; Bianchi G; Page CP
    Br J Pharmacol; 1993 Dec; 110(4):1565-71. PubMed ID: 8306102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombolytic activity of defibrotide against old venous thrombi.
    Niada R; Porta R; Pescador R; Mantovani M; Prino G
    Semin Thromb Hemost; 1989 Oct; 15(4):474-9. PubMed ID: 2510300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of a new antithrombotic agent (defibrotide) in acute renal failure due to thrombotic microangiopathy.
    Bonomini V; Frascà GM; Raimondi C; Liviano D'arcangelo G; Vangelista A
    Nephron; 1985; 40(2):195-200. PubMed ID: 3839050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulation of vascular prostacyclin and inhibition of platelet function by oral defibrotide in cholesterol-fed rabbits.
    Löbel P; Schrör K
    Atherosclerosis; 1989 Nov; 80(1):69-79. PubMed ID: 2513813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of defibrotide in electrically induced thrombosis in dogs.
    Ulutin ON; Tunali H; Uğur MS; Aytiş S; Erbengi T; Balkuv-Ulutin S
    Haemostasis; 1986; 16 Suppl 1():9-12. PubMed ID: 3754839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrinolytic effects of defibrotide in atherosclerotic patients.
    Patrassi GM; Sartori MT; Viero ML; Scapinello MP; Boeri G; Girolami A
    Semin Thromb Hemost; 1991; 17 Suppl 1():101-5. PubMed ID: 2068562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pharmacology and clinical pharmacology of defibrotide: a new profibrinolytic, antithrombotic and anti-platelet substance.
    Ulutin ON; Balkuv-Ulutin S; Ugur MS; Ulutin T; Ozsoy Y; Cizmeci G
    Adv Exp Med Biol; 1990; 281():429-38. PubMed ID: 2102624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defibrotide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in vascular disorders.
    Palmer KJ; Goa KL
    Drugs; 1993 Feb; 45(2):259-94. PubMed ID: 7681375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of defibrotide in patients with chronic deep insufficiency. The PROVEDIS study.
    Coccheri S; Andreozzi GM; D'Addato M; Gensini GF;
    Int Angiol; 2004 Jun; 23(2):100-7. PubMed ID: 15507885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective stimulation of coronary vascular PGI2 but not of platelet thromboxane formation by defibrotide in the platelet perfused heart.
    Löbel P; Schrör K
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Nov; 331(2-3):125-30. PubMed ID: 3937058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defibrotide: properties and clinical use of an old/new drug.
    Pescador R; Capuzzi L; Mantovani M; Fulgenzi A; Ferrero ME
    Vascul Pharmacol; 2013; 59(1-2):1-10. PubMed ID: 23680861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Use of defibrotide in the treatment of acute superficial thrombophlebitis of the legs].
    Seccia M; Bortolotti P; Bellomini MG; Buccianti P; Chiarugi M; Cavina E
    Minerva Chir; 1989 May; 44(9):1379-84. PubMed ID: 2761740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel mechanism of action of a prostacyclin enhancing agent in haemorrhagic shock.
    Bitterman H; Lefer DJ; Lefer AM
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Jun; 337(6):679-86. PubMed ID: 3063971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapy of deep venous thrombosis with defibrotide. Pilot study].
    Sammarco M; Garofalo M; Nazzari M
    Minerva Med; 1988 Jun; 79(6):495-7. PubMed ID: 2967927
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.